Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke

GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning and thrombolytic reperfusion therapies in stroke

US Patent 11246861 · Granted Feb 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating stomach cancer2022
Method for treating a patient having a colon cancer2022
GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thr2022
GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thr2022
GSNO reductase inhibitor as an adjunct therapy in cerebral thrombosis and/or thr2022
Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereof2022
Method for making anti-cancer compounds2022
Anticancer compounds, pharmaceutical compositions thereof, and a method of treat2021
Anti-cancer compounds having oxazolone derivation2021
Pharmaceutical composition for treating cancer2021
Method for treating a patient having cancer2021
GSNO reductase inhibitor as an adjunct therapy with remote ischemic conditioning2021